MMP23B

From WikiMD's WELLNESSPEDIA


Matrix metallopeptidase 23B (MMP23B) is a member of the matrix metalloproteinase (MMP) family, which is involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis.

Structure[edit]

MMP23B is a unique member of the MMP family due to its distinct structure. Unlike other MMPs, MMP23B lacks a signal peptide and a propeptide domain, which are typically involved in the regulation of MMP activity. Instead, MMP23B contains a type II transmembrane domain, suggesting that it is anchored to the cell membrane. The protein also contains a cysteine array and an immunoglobulin-like domain, which are not found in other MMPs.

Function[edit]

The precise biological function of MMP23B is not fully understood. However, it is believed to play a role in the regulation of cell proliferation, apoptosis, and differentiation. MMP23B is expressed in a variety of tissues, including the ovary, testis, and placenta, indicating a potential role in reproductive processes.

Clinical Significance[edit]

Alterations in MMP23B expression have been associated with various pathological conditions. For example, overexpression of MMP23B has been observed in certain types of cancer, suggesting a potential role in tumor progression and metastasis. However, the exact mechanisms by which MMP23B contributes to these processes remain to be elucidated.

Research Directions[edit]

Current research is focused on understanding the regulatory mechanisms controlling MMP23B expression and activity, as well as its interactions with other proteins and signaling pathways. Studies are also investigating the potential of MMP23B as a therapeutic target in cancer and other diseases.

Also see[edit]

Template:Matrix metalloproteinases


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.